Vanguard Group’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.22M | Sell |
2,103,032
-253,801
| -11% | -$629K | ﹤0.01% | 3205 |
|
|
2025
Q1 | $3.65M | Sell |
2,356,833
-57,108
| -2% | -$88.5K | ﹤0.01% | 3285 |
|
|
2024
Q4 | $5.17M | Buy |
2,413,941
+95,930
| +4% | +$205K | ﹤0.01% | 3261 |
|
|
2024
Q3 | $10.1M | Buy |
2,318,011
+186,387
| +9% | +$811K | ﹤0.01% | 2954 |
|
|
2024
Q2 | $9.93M | Buy |
2,131,624
+226,324
| +12% | +$1.05M | ﹤0.01% | 2930 |
|
|
2024
Q1 | $9.66M | Sell |
1,905,300
-41,793
| -2% | -$212K | ﹤0.01% | 2975 |
|
|
2023
Q4 | $5.47M | Sell |
1,947,093
-16,490
| -0.8% | -$46.3K | ﹤0.01% | 3251 |
|
|
2023
Q3 | $5.64M | Buy |
1,963,583
+482,198
| +33% | +$1.38M | ﹤0.01% | 3199 |
|
|
2023
Q2 | $7.48M | Buy |
1,481,385
+723,800
| +96% | +$3.66M | ﹤0.01% | 3112 |
|
|
2023
Q1 | $1.43M | Hold |
757,585
| – | – | ﹤0.01% | 3793 |
|
|
2022
Q4 | $1.36M | Buy |
757,585
+487
| +0.1% | +$877 | ﹤0.01% | 3803 |
|
|
2022
Q3 | $1.28M | Buy |
757,098
+92,141
| +14% | +$156K | ﹤0.01% | 3922 |
|
|
2022
Q2 | $1.64M | Sell |
664,957
-11,730
| -2% | -$28.9K | ﹤0.01% | 3894 |
|
|
2022
Q1 | $1.88M | Sell |
676,687
-338,104
| -33% | -$937K | ﹤0.01% | 3986 |
|
|
2021
Q4 | $5.41M | Sell |
1,014,791
-85,032
| -8% | -$453K | ﹤0.01% | 3562 |
|
|
2021
Q3 | $9.3M | Sell |
1,099,823
-460,636
| -30% | -$3.9M | ﹤0.01% | 3282 |
|
|
2021
Q2 | $19M | Sell |
1,560,459
-315,526
| -17% | -$3.85M | ﹤0.01% | 2871 |
|
|
2021
Q1 | $45.5M | Buy |
1,875,985
+30,023
| +2% | +$728K | ﹤0.01% | 2371 |
|
|
2020
Q4 | $59.2M | Buy |
1,845,962
+221,810
| +14% | +$7.11M | ﹤0.01% | 2115 |
|
|
2020
Q3 | $49.1M | Buy |
1,624,152
+788,646
| +94% | +$23.8M | ﹤0.01% | 2027 |
|
|
2020
Q2 | $35.2M | Buy |
835,506
+202,540
| +32% | +$8.54M | ﹤0.01% | 2177 |
|
|
2020
Q1 | $15.8M | Buy |
+632,966
| New | +$15.8M | ﹤0.01% | 2397 |
|